financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Mp Materials Corp.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Mp Materials Corp.
May 3, 2024 11:02 AM

01:40 PM EDT, 05/03/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target of $24 implies an EV/EBITDA multiple of 21.0x our 2025 EBITDA estimate vs. MP's three-year average forward EV/EBITDA of 26.2x. We lower our 2024 EPS estimate by $0.68 to a loss per share of -$0.20 and our 2025 EPS forecast by $1.05 to $0.53. MP posted a Q1 adj. loss per share of -$0.04 vs. EPS of $0.27, $0.01 below consensus; sales beat consensus by 3%. Q1 production of 11,151 metric tons (MT) of rare earth oxide (REO) was up 4.5% Y/Y and up 20% sequentially. The realized REO price in Q1 was $4,294 per MT, down 54% Y/Y and down 24% Q/Q. Q1 sales volume of 9,332 MT was 16.3% below production, due to stockpiling required to scale-up NdPr seperation. MP is currently suffering from low prices (both REO and NdPr) and lower profits driven by investing in working capital for NdPr separation and ongoing investment in magnetics. We think MP is very compelling as we see a high probability that prices will rebound later in 2024, which is a catalyst that should send MP shares significantly higher.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Mar 24, 2025
04:45 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $331 from $304 based on our Net Present Value (NPV) analysis. We lower our 2025 EPS estimate to -$1.62 from $0.30 our 2026 EPS...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Research Alert: CFRA Keeps Hold Opinion On Shares Of Darden Restaurants Inc
Mar 24, 2025
02:15 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $16 to $216, 20x (from 19x) our FY 26 (May) EPS of $10.83 (from $10.50) and in line with its three-year historical average forward...
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Mar 24, 2025
01:35 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our USD8 target (2x 2025 P/B) and Strong Sell rating on XPeng ( XPEV ). The company reported 2024 revenue growth of 33.2% to CNY40.87B, with gross margin...
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Research Alert: CFRA Raises Opinion On Shares Of Vf Corporation To Hold From Sell
Mar 24, 2025
03:25 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month price target of $19 is based on 15.2x our FY 26 (Mar.) EPS estimate and in line with the company's three-year average forward P/E multiple of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved